Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
STAR Protocols|May 15, 2024
Protocol to generate scaffold-free, multicomponent 3D melanoma spheroid models for preclinical drug testingCristian Angeli, Joanna Patrycja Wroblewska, Eliane Klein, et al.Frontiers in Oncology|December 28, 2020
Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of ImmunotherapyEliane Klein, Ann-Christin Hau, Anaïs Oudin, et al.STAR Protocols|June 14, 2025
Protocol for sub-mucosal orthotopic injection of organoids into murine colon to study tumor growth and metastasisSura Atatri, Marianne Meyers, Eliane Klein, et al.Journal of Experimental & Clinical Cancer Research : CR|October 2, 2025
High-throughput drug screening in advanced pre-clinical 3D melanoma models identifies potential first-line therapies for NRAS-mutated melanomaCristian Angeli, Demetra Philippidou, Eliane Klein, et al.Molecular Oncology|November 13, 2024
Adenoviral delivery of the CIITA transgene induces T-cell-mediated killing in glioblastoma organoidsIlaria Salvato, Eliane Klein, Aurélie Poli, et al.Neuro-Oncology Advances|July 10, 2020
The soluble form of pan-RTK inhibitor and tumor suppressor LRIG1 mediates downregulation of AXL through direct protein-protein interaction in glioblastomaVirginie Neirinckx, Ann-Christin Hau, Anne Schuster, et al.STAR Protocols|May 24, 2021
Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumorsAnaïs Oudin, Virginie Baus, Vanessa Barthelemy, et al.Nature Communications|December 14, 2020
AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasionAnne Schuster, Eliane Klein, Virginie Neirinckx, et al.The EMBO Journal|August 22, 2025
Fusobacterium nucleatum interacts with cancer-associated fibroblasts to promote colorectal cancerJessica Karta, Marianne Meyers, Fabien Rodriguez, et al.Acta Neuropathologica|October 3, 2020
Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncologyAnna Golebiewska, Ann-Christin Hau, Anaïs Oudin, et al.Pageof 1